205 related articles for article (PubMed ID: 34405012)
1. A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological malignancy patients receiving chemotherapy.
Chen S; Lin K; Li Q; Luo X; Xiao M; Chen M; Zhu H; Chen Y; Wu X; Zeng Y; Zhang Y; Ally IH; Xu J; Ren J; Chen Z; Hu J; Yang T
J Cancer; 2021; 12(18):5494-5505. PubMed ID: 34405012
[No Abstract] [Full Text] [Related]
2. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection.
Di Domenico EG; Marchesi F; Cavallo I; Toma L; Sivori F; Papa E; Spadea A; Cafarella G; Terrenato I; Prignano G; Pimpinelli F; Mastrofrancesco A; D'Agosto G; Trento E; Morrone A; Mengarelli A; Ensoli F
Microbiol Spectr; 2021 Sep; 9(1):e0055021. PubMed ID: 34406812
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic spectrum and drug resistance of bloodstream infection in patients with acute myeloid leukaemia: a single centre retrospective study.
Wu H; Li M; Shou C; Shi F; Song X; Hu Q; Wang Y; Chen Y; Tong X
Front Cell Infect Microbiol; 2024; 14():1390053. PubMed ID: 38912203
[TBL] [Abstract][Full Text] [Related]
5. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
[TBL] [Abstract][Full Text] [Related]
6. Characteristics, Outcomes, and Clinical Indicators of Bloodstream Infections in Neutropenic Patients with Hematological Malignancies: A 7-Year Retrospective Study.
Wang S; Song Y; Shi N; Yin D; Kang J; Cai W; Duan J
Infect Drug Resist; 2023; 16():4471-4487. PubMed ID: 37449245
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, resistant pathogens, and causes of early death in cases of bloodstream infection in patients with hematological malignancies from 2012-2019.
Li M; Du M; Li H; Liu D; Liu Y
Infect Med (Beijing); 2022 Mar; 1(1):23-30. PubMed ID: 38074981
[TBL] [Abstract][Full Text] [Related]
8. The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections.
Lu L; Xu C; Tang Y; Wang L; Cheng Q; Chen X; Zhang J; Li Y; Xiao H; Li X
Infect Drug Resist; 2022; 15():2901-2914. PubMed ID: 35693849
[TBL] [Abstract][Full Text] [Related]
9. Comparison of epidemiological, clinical and microbiological characteristics of bloodstream infection in children with solid tumours and haematological malignancies.
Garrido MM; Garrido RQ; Cunha TN; Ehrlich S; Martins IS
Epidemiol Infect; 2019 Nov; 147():e298. PubMed ID: 31699182
[TBL] [Abstract][Full Text] [Related]
10. Microbiology and prognostic prediction model of bloodstream infection in patients with hematological malignancies.
Wang J; Wang M; Zhao A; Zhou H; Mu M; Liu X; Niu T
Front Cell Infect Microbiol; 2023; 13():1167638. PubMed ID: 37457950
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China.
Jiang AM; Shi X; Liu N; Gao H; Ren MD; Zheng XQ; Fu X; Liang X; Ruan ZP; Yao Y; Tian T
BMC Infect Dis; 2020 Jun; 20(1):452. PubMed ID: 32600270
[TBL] [Abstract][Full Text] [Related]
12. Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population.
Gill EL; Gill CM; McEvoy C
Ann Hematol; 2024 May; 103(5):1745-1752. PubMed ID: 38453704
[TBL] [Abstract][Full Text] [Related]
13. Gram-Negative Bacteria Bloodstream Infections in Patients with Hematological Malignancies - The Impact of Pathogen Type and Patterns of Antibiotic Resistance: A Retrospective Cohort Study.
Tang Y; Xu C; Xiao H; Wang L; Cheng Q; Li X
Infect Drug Resist; 2021; 14():3115-3124. PubMed ID: 34413656
[TBL] [Abstract][Full Text] [Related]
14.
Royo-Cebrecos C; Laporte-Amargós J; Peña M; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo M; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Morales HMP; Brunel AS; García E; Isler B; Kern WV; Palacios-Baena ZR; de la Calle GM; Montero MM; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmatti P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Carratalà J; Gudiol C;
Pathogens; 2022 Sep; 11(10):. PubMed ID: 36297188
[TBL] [Abstract][Full Text] [Related]
15. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013.
Chen CY; Tien FM; Sheng WH; Huang SY; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR
Int J Antimicrob Agents; 2017 Mar; 49(3):272-281. PubMed ID: 28109554
[TBL] [Abstract][Full Text] [Related]
16. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
Cattaneo C; Di Blasi R; Skert C; Candoni A; Martino B; Di Renzo N; Delia M; Ballanti S; Marchesi F; Mancini V; Orciuolo E; Cesaro S; Prezioso L; Fanci R; Nadali G; Chierichini A; Facchini L; Picardi M; Malagola M; Orlando V; Trecarichi EM; Tumbarello M; Aversa F; Rossi G; Pagano L;
Ann Hematol; 2018 Sep; 97(9):1717-1726. PubMed ID: 29705860
[TBL] [Abstract][Full Text] [Related]
17. Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study.
Kern WV; Roth JA; Bertz H; Götting T; Dettenkofer M; Widmer AF; Theilacker C;
Transpl Infect Dis; 2019 Dec; 21(6):e13186. PubMed ID: 31574202
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and drug resistance analysis of bloodstream infections in an intensive care unit from a children's medical center in Eastern China for six consecutive years.
Shao H; Zhang X; Li Y; Gao Y; Wang Y; Shao X; Dai L
Int Microbiol; 2024 Jan; ():. PubMed ID: 38233723
[TBL] [Abstract][Full Text] [Related]
19. Bloodstream infections caused by Klebsiella pneumoniae: prevalence of bla
Xu M; Fu Y; Kong H; Chen X; Chen Y; Li L; Yang Q
BMC Infect Dis; 2018 Jul; 18(1):358. PubMed ID: 30064360
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough bloodstream infections in critically ill non-neutropenic patients: higher incidence and better survival than non-breakthrough infections.
Papadimitriou-Olivgeris M; Kolonitsiou F; Solomou A; Karamouzos V; Anastassiou ED; Christofidou M; Spiliopoulou I; Fligou F; Marangos M
J Med Microbiol; 2019 Oct; 68(10):1544-1551. PubMed ID: 31436523
[No Abstract] [Full Text] [Related]
[Next] [New Search]
